These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

75 related articles for article (PubMed ID: 5031465)

  • 1. [Synthesis of pyrrolidonecarboxylic acid (PCA). Report].
    Jacórzyński B
    Rocz Panstw Zakl Hig; 1972; 23(1):73-5. PubMed ID: 5031465
    [No Abstract]   [Full Text] [Related]  

  • 2. Pyrrolidinones derived from (S)-pyroglutamic acid: penmacric acid and analogues.
    Anwar M; Bailey JH; Dickinson LC; Edwards HJ; Goswami R; Moloney MG
    Org Biomol Chem; 2003 Jul; 1(13):2364-76. PubMed ID: 12945710
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [Synthesis and pharmacological activity of some carboxy pyrrolidinones and several derivatives (author's transl)].
    Robert J; Boucherle A
    Ann Pharm Fr; 1981; 39(4):337-46. PubMed ID: 7305244
    [No Abstract]   [Full Text] [Related]  

  • 4. [Chemico-pharmaceutical and pharmacodynamic characteristics of pyrglutargine].
    Selleri R; Orzalesi G; Innocenti F; Volpato I; Bisagno T
    Boll Chim Farm; 1977 Dec; 116(12):735-43. PubMed ID: 610732
    [No Abstract]   [Full Text] [Related]  

  • 5. From N-triisopropylsilylpyrrole to an optically active C-4 substituted pyroglutamic acid: total synthesis of penmacric acid.
    Berini C; Pelloux-Léon N; Minassian F; Denis JN
    Org Biomol Chem; 2009 Nov; 7(21):4512-6. PubMed ID: 19830303
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Synthesis and angiotensin-converting enzyme inhibitory activity of 3-(Mercaptomethyl)-2-oxo-1-pyrrolidineacetic acids and 3-(Mercaptomethyl)-2-oxo-1-piperidineacetic acids.
    Klutchko S; Hoefle ML; Smith RD; Essenburg AD; Parker RB; Nemeth VL; Ryan MJ; Dugan DH; Kaplan HR
    J Med Chem; 1981 Jan; 24(1):104-9. PubMed ID: 6259352
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Expedient synthesis of N-Z-pyroglutamyl-amino acid derivatives.
    Katritzky AR; Angrish P; Todadze E; Ghiviriga I
    Bioorg Med Chem Lett; 2007 Nov; 17(21):6000-2. PubMed ID: 17845849
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [The molecular structure of N-hydroxymethylpyrrolidone carboxylic acid. The structure determination of the reaction product of L-pyroglutamic acid with formaldehyde (author's transl)].
    Kanao S; Nagashima N
    Yakugaku Zasshi; 1978 Mar; 98(3):293-6. PubMed ID: 565811
    [No Abstract]   [Full Text] [Related]  

  • 9. Synthesis of new optically active 2-pyrrolidinones.
    Moutevelis-Minakakis P; Papavassilopoulou E; Mavromoustakos T
    Molecules; 2012 Dec; 18(1):50-73. PubMed ID: 23344188
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Preparation and characterization of novel pyrrol-3-ones attached to alpha/beta-amino acids, esters and amides.
    Saçmaci M; Ungören SH; Akçamur Y
    Amino Acids; 2006 Nov; 31(4):397-401. PubMed ID: 16729189
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Diastereoselective syntheses of deoxydysibetaine, dysibetaine, and its 4-epimer.
    Langlois N; Le Nguyen BK
    J Org Chem; 2004 Oct; 69(22):7558-64. PubMed ID: 15497982
    [TBL] [Abstract][Full Text] [Related]  

  • 12. A facile solid phase synthesis of tetramic acid.
    Liu Z; Ruan X; Huang X
    Bioorg Med Chem Lett; 2003 Aug; 13(15):2505-7. PubMed ID: 12852953
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Hair and amino acids: the interactions and the effects.
    Oshimura E; Abe H; Oota R
    J Cosmet Sci; 2007; 58(4):347-57. PubMed ID: 17728935
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Therapy of hyperammonemia: effect of a preparation arginine pyrrolidonecarboxylate, taurine, vitamin B6 and citric acid].
    Verzetti G; Emanuelli G; Montagnani M
    Clin Ter; 1972 Mar; 60(5):429-38. PubMed ID: 5038775
    [No Abstract]   [Full Text] [Related]  

  • 15. Amino acids are not un-charged (lipid-soluble) substances. Why we might as well forget pyroglutamate as an amino acid.
    Christensen HN
    Trends Pharmacol Sci; 1988 Dec; 9(12):430. PubMed ID: 3273495
    [No Abstract]   [Full Text] [Related]  

  • 16. The occurrence of neurotoxic pyroglutamic acid in parenteral amino acid solutions. Specific determination by means of capillary isotachophoresis.
    Stehle P; Fürst P
    Clin Chim Acta; 1987 Nov; 169(2-3):323-7. PubMed ID: 3123102
    [No Abstract]   [Full Text] [Related]  

  • 17. [Use of magnesium pyrrolidonecarboxylic acid in uterine dyskinesia].
    Puech F; Delecour M
    Lille Med; 1976 Sep; 21(7 Suppl 3):602-5. PubMed ID: 994689
    [No Abstract]   [Full Text] [Related]  

  • 18. Synthesis of cis-4-trifluoromethyl- and cis-4-difluoromethyl-l-pyroglutamic acids.
    Qiu XL; Qing FL
    J Org Chem; 2003 May; 68(9):3614-7. PubMed ID: 12713369
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Chemical method for identification of N-blocked group in pyroglutamic acid peptides.
    Gupta S; Sharma K; Narang CK; Mathur NK
    Indian J Biochem Biophys; 1984 Apr; 21(2):133-4. PubMed ID: 6490073
    [No Abstract]   [Full Text] [Related]  

  • 20. Stereoselective synthesis of conformationally constrained omega-amino acid analogues from pyroglutamic acid.
    Bentz EL; Goswami R; Moloney MG; Westaway SM
    Org Biomol Chem; 2005 Aug; 3(15):2872-82. PubMed ID: 16032366
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 4.